They revealed a decrease in itaconate and itaconate-synthesizing cis-aconitate decarboxylase (ACOD1) levels in AMs from IPF patients in comparison with controls, suggesting a dysregulated axis. The gene discussed is ACOD1; the disease is idiopathic pulmonary fibrosis.